Skip to main content
Fig. 1 | BMC Pulmonary Medicine

Fig. 1

From: Impact of a bronchial genomic classifier on clinical decision making in patients undergoing diagnostic evaluation for lung cancer

Fig. 1

Impact of low risk (negative) bronchial genomic classifier results on decision to take patients to an additional procedure after an inconclusive bronchoscopy. When physicians were presented cases with low risk classifier results (n = 251), 18 % of the time they recommended a procedure, a three-fold reduction from when physicians were presented blinded cases associated with low risk classifier results (57 % invasive procedure rate, n = 268, p < 0.001)

Back to article page